Support: 1-888-506-6887
Worldwide flag      (Choose your country)  
Home » About Us » Newsletters
Get in touch with us on Facebook and Twitter for the latest on antibody news and promotions!
Newsletters
This page contains an archive of our research area specific eNewsletters. If you would like to be kept up to date on new products, promotions, and up and coming events, sign up to receive Novus eNews. Create a new account here, or if you already have an account, login and click on Profile.
Immunology Newsletter - 10th Edition
In this edition of the Immunology Newsletter, read a spotlight on Edward Jenner, regarded as the father of immunology. Also learn more about Novus' extensive catalog of viral research related antibodies.
Epigenetics Newsletter - 14th Edition
In this edition of the Epigenetics Newsletter, read a spotlight on histone deacetylases.
Autophagy Newsletter - 15th Edition
In this edition, LC3 related antibodies for autophagy research are spotlighted.
Cancer Newsletter - 17th Edition
In this edition of Cancer eNews, read a spotlight on AACR and cancer research antibodies.
Cell Signaling Newsletter - 5th Edition
this edition of the Cell Signaling Newsletter, read a spotlight on Integrin ECM Signaling. Also browse the wide selection of top quality integrin research reagents, including antibodies, lysates, proteins and RNAi that Novus has to offer.
Lipid & Metabolism eNews- 16th Edition
In this edition of the Lipid & Metabolism Newsletter, read a spotlight on some of Novus' most popular antibodies for glycolysis related studies.
Cell Cycle and Development Newsletter - 4th Edition
In this edition of the Cell Cycle & Development Newsletter, mitotic marker antibodies are spotlighted.
Hypoxia Newsletter - 15th Edition
In this edition, read a spotlight on tumor hypoxia and learn why Novus is the leading supplier of top quality tumor hypoxia biomarker antibodies.
Apoptosis Newsletter - 14th Edition
In this edition, read a spotlight on the role of apoptosis in HIV progression. Also, learn more about the top quality HIV and apoptosis related antibodies Novus has to offer.
Epigenetics Newsletter - 13th Edition
In this edition of the Epigenetics Newsletter, learn more about Novus’ modified histone specific Epi-Plus® antibodies. Also, for a limited time, buy one Epi-Plus® antibody at full price and get a second Epi-Plus® antibody free! Use promo code EPIPLUS13. Hurry, expires March 30, 2013!
Stem Cells Newsletter - 17th Edition
In this edition of the Stem Cell eNews, read a spotlight on NOTCH Stem Cell Signaling. Also explore some of our most popular NOTCH antibodies and read about NOTCH in the news.
Cardiology Newsletter - 2nd Edition
In this edition of the Cardiology eNews, read a spotlight on the Blood Coagulation Cascade. Also explore some of our most popular coagulation factor antibodies for WB and immunostaining human samples.
Neuroscience Newsletter - 15th Edition
In this edition, read a spotlight on Chondroitinase ABC (ChABC) and the major role it plays in the nervous system.
DNA Newsletter - 15th Edition
In this edition of the DNA Newsletter, read a spotlight on DNA repair and explore the featured antibodies Novus is highlighting for DNA repair.
Cancer Newsletter - 16th Edition
In this edition of Cancer eNews, read a spotlight on Protein Tyrosine Phosphatases.
Cell Signaling Newsletter - 4th Edition
In this edition of the Cell Signaling Newsletter, read a spotlight on the Leukocyte integrin subunit.
Stem Cells Newsletter - 16th Edition
In this edition of the Stem Cell eNews, read a spotlight on cancer stem cells.
Cell Signaling Newsletter - 3rd Edition
In this edition of the Cell Signaling Newsletter, the p38 MAPK signaling pathway is spotlighted. Also browse some of Novus' most popular antibodies in relation to the p38 MAPK signaling pathway.
Immunology Newsletter - 9th Edition
In this edition of the Immunology Newsletter, the NFkB signaling pathway is spotlighted. Also browse the top quality antibodies Novus offers for the NFkB signaling pathway.
Cell Cycle and Development Newsletter - 2nd Edition
In this edition of the Cell Cycle & Development Newsletter, the MAPK/ERK pathway is spotlighted. Also explore the variety of antibodies, proteins, peptides and RNAi Novus offers for all your research needs.
DNA Newsletter - 14th Edition
In this edition of the DNA Newsletter, APE1 and FANCD2 is spotlighted. Also explore the different antibodies, RNAi and control lysates Novus offers for DNA repair.
Stem Cells Newsletter - 15th Edition
In this edition of the Stem Cell eNews, the TGF beta pathway is spotlighted.
Neuroscience Newsletter - 14th Edition
In this edition, learn more about the excellent antibodies Novus offers for several areas of epigenetic control of neural activity. Also, remember to stop by booth number 723 to meet a Novus representative at the Society for Neuroscience Convention in New Orleans, Louisiana from October 13-17.
Autophagy Newsletter - 14th Edition
In this edition, Beclin 1 antibodies for Autophagy research are spotlighted. Also learn more about many other specific antibodies and control reagents Novus offers for your Autophagy research.
Epigenetics Newsletter – 11th Edition
In this edition of the Epigenetics Newsletter, read about the new Chromatin Modifiers and Epi-Plus antibodies Novus has to offer.
Lipid & Metabolism eNews- 14th Edition
In this edition of the Lipid & Metabolism Newsletter, the insulin receptor signaling pathway is spotlighted. Also read about the featured insulin receptor related antibodies Novus has to offer.
Cancer Newsletter - 14th Edition
In this edition of Cancer eNews, learn more about some of Novus' most popular cancer antibodies.
Cell Signaling Newsletter -2nd Edition
In this edition of the Cell Signaling eNews, learn more about the AKT signaling pathway and the thousands of antibodies Novus offers for Cell Signaling Research.
Hypoxia Newsletter - 14th Edition
In this edition, hypoxia and inflammation using HIF and NFkB antibodies is spotlighted.
Cell Cycle & Development Newsletter - 1st Edition
In our first ever edition of the Cell Cycle & Development Newsletter, learn all about the HIPPO Signaling Pathway. Also explore a number of top quality antibodies that Novus offers for the HIPPO signaling pathway.
Immunology Newsletter - 8th Edition
In this edition of the Immunology Newsletter, the early hematopoietic zinc finger protein (ZNF521) is spotlighted.
Cardiology Newsletter - 1st Edition
In our first ever edition of the Cardiology eNews, read about a spotlight on Circadian Rhythm Antibodies (BMAL1, CLOCK & PER2) and their importance in Cardiovascular Research.
Cancer Newsletter- 13th Edition
In this edition of Cancer eNews, read about and browse the variety of antibodies Novus offers to aid in the study of cancer, epigenetics and stem cell research.
Cell Signaling Newsletter -1st Edition
In our first ever edition of Cell Signaling eNews, learn about Autoimmune Disease and its relation to Cell Signaling. Also read more about our featured cell adhesion antibodies.
Lipid & Metabolism eNews- 13th Edition
Learn about FABP, Diabetes and Obesity and how it's related to Lipid and Metabolism research. Also check out our featured FABP and other Lipid related Antibodies.
Stem Cells Newsletter - 14th Edition
In this edition, Stem Cell Signaling research and featured Stem Cells Antibodies are highlighted. Also, don't forget to stop by the Novus booth June 13-16th in Yokohama, Japan for the International Society for Stem Cell Researchers (ISSCR) Conference.
Autophagy Newsletter- 13th Edition
ATG5, ATG12, and LC3I Antibodies for Autophagy research are spotlighted in this edition. Also read about recommended publications related to Autophagy.
Apoptosis Newsletter - 13th Edition
In this edition, Caspase Recruitment Domain (CARD) is spotlighted. Also read about Novus' newly released antibodies and recommended CARD publications.
Hypoxia Newsletter - 13th Edition
In this edition, read why Novus continues to be the leading provider of HIF reagents across the world. Also learn more about our HIF Antibody Packs and take a look at some featured HIF customer reviews.
Stem Cells Newsletter - 13th Edition
In this edition, read all about Dicer and DGCR8 Knockout Embryonic Stem Cells.